Investigated event: Inlfuence on cell viability
| Name | Value |
|---|---|
| Compound | Gefitinib |
| Investigated event | Inlfuence on cell viability |
| Experiment type | CCK8 assay |
| Concentration | 10.00 µM |
| Cell line | NCI‑H1975 |
| Organism | Homo sapiens |
| Animal model | |
| STAT protein | |
| Other |
Reference
Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway. Molecular medicine reports Hong Jin, Ai-Ying Jiang, Han Wang, Yong Cao, Yan Wu, Xiao-Feng Jiang, 16, 3, None, 2017-07-14, 10.3892/mmr.2017.6989
DOI: 10.3892/mmr.2017.6989
PUBMED: 28713965
PMCID: 28713965